Loading...
01/11 03:11
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call summary indicates a mixed performance: strong Q1 revenue but weak Q2 guidance with a projected revenue decline and negative operating margins. Additionally, a net loss due to impairment charges and legislative uncertainties affecting demand are concerning. The Q&A reveals stable demand but no clear growth catalysts, with management avoiding specifics on key issues like retrogression. Despite some positive signs (e.g., new partnerships), the overall sentiment is negative, particularly given the market cap, as smaller companies tend to react more strongly to such mixed signals.
Second Quarter Revenue $658 million, down 11% year-over-year, driven primarily by lower volume in Nurse and Allied segment.
Adjusted EBITDA $58 million, down 38% year-over-year, due to lower revenue and higher SG&A expenses.
Gross Margin 29.8%, decreased 120 basis points year-over-year, primarily due to lower revenue and adverse revenue mix.
SG&A Expenses $155 million, up from $149 million in the prior year, driven by a $5 million unfavorable professional liability reserve adjustment and $2 million in higher bad debt expense.
Nurse and Allied Revenue $382 million, down 14% year-over-year, driven mainly by lower volume, partially offset by labor disruption revenue.
Travel Nurse Revenue $208 million, down 25% year-over-year, due to lower volume and average rate.
Allied Revenue $146 million, down 4% year-over-year, due to lower volume.
Physician and Leadership Solutions Revenue $175 million, down 6% year-over-year, driven by lower volume across the search and interim leadership businesses.
Locum Tenens Revenue $143 million, flat year-over-year, due to stable demand.
Technology and Workforce Solutions Revenue $102 million, down 9% year-over-year, primarily driven by declines in VMS and outsourced solutions businesses.
Language Services Revenue $76 million, up 1% year-over-year, due to increased utilization offset by competitive pricing pressure.
Adjusted EBITDA Margin 8.9%, down 380 basis points year-over-year, due to lower revenue and higher SG&A expenses.
Net Loss $116 million, compared to net income of $16 million in the prior year, driven by goodwill and intangible asset impairment charges.
Operating Cash Flow $79 million, favorably impacted by a $50 million increase in client deposits related to labor disruption events.
Televate virtual care platform: Innovative solution contributing to strong bookings in Allied Schools business, expected to drive double-digit volume growth in Q4.
AMN Passport app: Expanded capabilities to manage float pool workers and labor disruption events, surpassing 300,000 registered users. Over 20% of Nurse and Allied placements are now assisted by Passport automation.
AI-enabled event management technology: Recently completed, receiving positive client reactions and enabling scalability for client support.
International nurse staffing: Positioned for sequential growth in Q4 2025, with growth trends expected to continue into 2026 due to Visa retrogression dates moving forward.
Locum tenens: Demand in Q3 is 5% higher than Q2, with consistent year-over-year growth expected starting Q3.
MSP revenue: Expected to reach a historic high in 2025, driven by higher same-client sales and new growth opportunities in locum.
Operational speed and automation: Improved fill rates in AMN-led MSPs and vendor-neutral programs, supported by a healthy pipeline of opportunities.
Cost structure management: Focus on managing costs and driving operational efficiency amid industry challenges.
Sale of Smart Square scheduling software: Sold for $75 million to symplr, enabling expansion of technology partnerships for workforce planning and staffing.
Diversification of revenues: Progress in building technology-enabled services and stabilizing staffing market share.
Government Policy Uncertainty: Uncertainty about government policy impact placed the healthcare sector in a cautious stance, leading to declines in staffing orders and extensions. Travel Nurse orders in June were 15% lower than March, and rebook retention rates for travelers fell through the quarter.
Federal Funding Cuts: Academic medical centers, which account for 20% of consolidated revenue, have reduced spending in response to cuts in federal funding for research.
Hiring Freezes: Hiring freezes have hampered the physician search business and likely affected demand in locum tenens.
Competitive Pricing Pressure: Language Services revenue faced competitive pricing pressure, offsetting utilization growth.
Decline in Travel Nurse Revenue: Travel Nurse revenue decreased 25% year-over-year and 4% sequentially, driven by lower volume and demand.
Impairment Charges: The company recorded a noncash goodwill impairment charge of $110 million related to the Physician and Leadership Solutions segment and an $18 million intangible asset impairment charge related to the Nurse and Allied segment.
Debt Levels: The company has total debt of $920 million, including $70 million drawn on a revolver, with a net leverage ratio of 3.3x to 1.
Seasonal and Segment-Specific Declines: Revenue for the Nurse and Allied segment was down 14% year-over-year, with labor disruption revenue significantly lower than the previous quarter. Interim leadership and search revenues also saw significant year-over-year declines.
Bad Debt Expense: The Physician and Leadership Solutions segment experienced $2 million in higher bad debt expense, impacting financial performance.
Decline in VMS Revenue: Technology and Workforce Solutions segment saw a 31% year-over-year decline in VMS revenue, contributing to a 510 basis point drop in gross margin for the segment.
Revenue Projections: Consolidated revenue for Q3 2025 is projected to be in the range of $610 million to $625 million, including $5 million related to labor disruption support.
Gross Margin: Gross margin for Q3 2025 is expected to be between 28.7% and 29.2%.
Operating Margin: Operating margin for Q3 2025 is projected to be between 6% and 6.5%.
Adjusted EBITDA Margin: Adjusted EBITDA margin for Q3 2025 is expected to be between 7.7% and 8.2%.
International Nurse Staffing: This segment is positioned to resume sequential growth in volume and revenue in Q4 2025, with growth trends continuing into 2026. The business anticipates outsized growth opportunities over the next 2 to 3 years as Visa retrogression dates move forward.
Allied Schools Business: Double-digit volume growth is expected in Q4 2025, driven by robust bookings in the first half of the year and innovative solutions like the Televate virtual care platform.
Locum Tenens Business: Consistent year-over-year growth is anticipated starting in Q3 2025, with demand in Q3 already 5% higher than Q2.
MSP Revenue: MSP revenue is expected to reach a historic high in 2025, supported by higher same-client sales and new growth opportunities in locum tenens.
Labor Disruption Business: Increased activity is anticipated from now into 2026, supported by upcoming collective bargaining agreements and AI-enabled event management technology.
The selected topic was not discussed during the call.
The earnings call summary and Q&A indicate a stable competitive market, growing demand for contingent labor, and positive business trends, such as increased MSP revenue and international nurse staffing growth. While management avoided specific guidance, the overall sentiment is positive with expected bill rate stabilization and strategic investments in technology. Given the company's market cap and the positive outlook, a 2% to 8% stock price increase is likely over the next two weeks.
The earnings call summary indicates a mixed performance: strong Q1 revenue but weak Q2 guidance with a projected revenue decline and negative operating margins. Additionally, a net loss due to impairment charges and legislative uncertainties affecting demand are concerning. The Q&A reveals stable demand but no clear growth catalysts, with management avoiding specifics on key issues like retrogression. Despite some positive signs (e.g., new partnerships), the overall sentiment is negative, particularly given the market cap, as smaller companies tend to react more strongly to such mixed signals.
The earnings call reveals a decline in financial performance across multiple revenue streams, with significant year-over-year drops and a net loss. Although there are some competitive wins in VMS and MSP and growth in language services, these are characterized as small to medium. The Q&A highlights competitive pressures and management's reluctance to provide specific guidance, which could increase uncertainty. The market cap suggests moderate sensitivity, leading to a prediction of a negative stock price movement in the range of -2% to -8% over the next two weeks.
The earnings call reveals significant challenges: declining gross margins, revenue, and net income, coupled with increased long-term debt. The Q&A highlighted margin pressure and competitive intensity, with management avoiding clarity on key issues. Despite some growth in specific segments, the overall sentiment is negative, reflecting weak financial performance and uncertain outlook. Given the company's small market cap, these factors are likely to drive a strong negative stock price reaction over the next two weeks.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
